BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22535243)

  • 1. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.
    Wang X; Sofocleous CT; Erinjeri JP; Petre EN; Gonen M; Do KG; Brown KT; Covey AM; Brody LA; Alago W; Thornton RH; Kemeny NE; Solomon SB
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):166-75. PubMed ID: 22535243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
    Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
    Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
    Sofocleous CT; Petre EN; Gonen M; Brown KT; Solomon SB; Covey AM; Alago W; Brody LA; Thornton RH; D'Angelica M; Fong Y; Kemeny NE
    J Vasc Interv Radiol; 2011 Jun; 22(6):755-61. PubMed ID: 21514841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study.
    Kurilova I; Bendet A; Petre EN; Boas FE; Kaye E; Gonen M; Covey A; Brody LA; Brown KT; Kemeny NE; Yarmohammadi H; Ziv E; D'Angelica MI; Kingham TP; Cercek A; Solomon SB; Beets-Tan RGH; Sofocleous CT
    Clin Colorectal Cancer; 2021 Jun; 20(2):e82-e95. PubMed ID: 33246789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
    Eur Radiol; 2021 Sep; 31(9):6489-6499. PubMed ID: 33447860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Najafi A; de Baere T; Purenne E; Bayar A; Al Ahmar M; Delpla A; Roux C; Madani K; Assouline J; Deschamps F; Tselikas L
    Eur Radiol; 2021 Jul; 31(7):5361-5369. PubMed ID: 33474569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraprocedural Versus Initial Follow-up Minimal Ablative Margin Assessment After Colorectal Liver Metastasis Thermal Ablation: Which One Better Predicts Local Outcomes?
    Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Fellman BM; Jones AK; Kuban JD; Huang SY; Metwalli ZA; Brock KK; Odisio BC
    Invest Radiol; 2024 Apr; 59(4):314-319. PubMed ID: 37812469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for liver metastasis from gastric cancer.
    Chen J; Tang Z; Dong X; Gao S; Fang H; Wu D; Xiang D; Zhang S
    Eur J Surg Oncol; 2013 Jul; 39(7):701-6. PubMed ID: 23597495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
    Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
    Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
    Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
    Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate Postablation
    Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
    J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Kaye EA; Cornelis FH; Petre EN; Tyagi N; Shady W; Shi W; Zhang Z; Solomon SB; Sofocleous CT; Durack JC
    Eur Radiol; 2019 May; 29(5):2698-2705. PubMed ID: 30402706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.